Lumira Ventures
Overview
Lumira Ventures is a North American life sciences venture capital firm that invests in transformative companies developing innovative therapeutics and medical technologies to improve patient health outcomes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HistoSonics | Aug 2025 | Buyout/LBO | Co-investor |
| XyloCor Therapeutics | Jan 2025 | Series B | Co-investor |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
| Nervonik | Apr 2026 | Series B | Co-investor |
| Contraline | Jun 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Peter van der Velden
Founder and Executive Chairperson, Founder and Managing Partner
Brian Underdown
Venture Partner
Ted Witek
Venture Partner Special Advisor
Iliana Carroll
Investment Partner
Lu Han 韩路
Partner, Partner
Nikhil Thatte
Partner, Senior Principal
Suman Rao
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lumira Ventures based?
Lumira Ventures is headquartered in Toronto, Ontario, Canada.
When was Lumira Ventures founded?
Lumira Ventures was founded in 2007.
How many portfolio companies does Lumira Ventures have?
Lumira Ventures has 36 portfolio companies in Caplight's dataset.
What are some companies in Lumira Ventures's portfolio?
Portfolio companies visible on Caplight include HistoSonics, XyloCor Therapeutics, Nocion Therapeutics, Nervonik, Contraline.
What was Lumira Ventures's most recent investment shown here?
Lumira Ventures's most recent investment in this portfolio sample was in Contraline in 2026.
What sectors does Lumira Ventures focus on?
Lumira Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Lumira Ventures focus on?
Lumira Ventures typically invests at the MultiStage stage.
What is Lumira Ventures's AUM?
Lumira Ventures's assets under management are estimated between $250.0M and $500.0M.